Literature DB >> 2010041

Role of oxidative stress in development of complications in diabetes.

J W Baynes1.   

Abstract

N epsilon-(carboxymethyl)lysine, N epsilon-(carboxymethyl)hydroxylysine, and the fluorescent cross-link pentosidine are formed by sequential glycation and oxidation reactions between reducing sugars and proteins. These compounds, termed glycoxidation products, accumulate in tissue collagen with age and at an accelerated rate in diabetes. Although glycoxidation products are present in only trace concentrations, even in diabetic collagen, studies on glycation and oxidation of model proteins in vitro suggest that these products are biomarkers of more extensive underlying glycative and oxidative damage to the protein. Possible sources of oxidative stress and damage to proteins in diabetes include free radicals generated by autoxidation reactions of sugars and sugar adducts to protein and by autoxidation of unsaturated lipids in plasma and membrane proteins. The oxidative stress may be amplified by a continuing cycle of metabolic stress, tissue damage, and cell death, leading to increased free radical production and compromised free radical inhibitory and scavenger systems, which further exacerbate the oxidative stress. Structural characterization of the cross-links and other products accumulating in collagen in diabetes is needed to gain a better understanding of the relationship between oxidative stress and the development of complications in diabetes. Such studies may lead to therapeutic approaches for limiting the damage from glycation and oxidation reactions and for complementing existing therapy for treatment of the complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010041     DOI: 10.2337/diab.40.4.405

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  650 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

Review 2.  Transition metals redox: reviving an old plot for diabetic vascular disease.

Authors:  V M Monnier
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Alterations in enzymatic antioxidant defence in diabetes mellitus--a rational approach.

Authors:  E Szaleczky; J Prechl; J Fehér; A Somogyi
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

Review 4.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

5.  Application of square-wave adsorptive stripping voltammetry to the study of cysteine and its interaction with some monosaccharides.

Authors:  S Cakir; E Biçer; O Cakir
Journal:  Glycoconj J       Date:  1999-10       Impact factor: 2.916

Review 6.  Congenital malformations in offspring of diabetic mothers--animal and human studies.

Authors:  Ulf J Eriksson; Jonas Cederberg; Parri Wentzel
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

7.  The chronological characteristics of SOD1 activity and inflammatory response in the hippocampi of STZ-induced type 1 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Dae Won Kim; Jae Hoon Shin; Sung Min Nam; Jung Hoon Choi; Choong Hyun Lee; Moo-Ho Won; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2010-10-06       Impact factor: 3.996

8.  Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism.

Authors:  K Prasad; S V Mantha; A D Muir; N D Westcott
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

9.  The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients.

Authors:  S Braschi; M Geoffrion; A Nguyen; Y Gaudreau; R W Milne
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

10.  Gallic acid modulates cerebral oxidative stress conditions and activities of enzyme-dependent signaling systems in streptozotocin-treated rats.

Authors:  I J Kade; J B T Rocha
Journal:  Neurochem Res       Date:  2013-02-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.